Creatine

Drug profile

Key facts

Creatine is a drug catalogued in DrugCentral.

• Molecular formula: C4H9N3O2; molecular weight 131.13 g/mol.

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
—	FDA	—	—

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Pneumonia aspiration	254.3
Coma	216.8
Gastrooesophageal reflux disease	190.1
Somnolence	160.9
Underdose	89.8
Incorrect route of product administration	52.2

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Creatine is on its molecule page.

• Molecular formula: C₄H₉N₃O₂
• Molecular weight: 131.13 g/mol
• CAS number: —
• InChIKey: CVSVTCORWBXHQV-UHFFFAOYSA-N
• PubChem CID: 586

CN(CC(O)=O)C(N)=N

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is the chemical formula of Creatine?

Creatine has the molecular formula C4H9N3O2 and a molecular weight of 131.13 g/mol.

Sources

• DrugCentral drug card 4661 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL283800 — compound record and bioactivity
• PubChem CID 586 — chemical identifiers
• DrugBank DB00148 — drug record
• FDA UNII MU72812GK0 — substance identity
• DailyMed: FDA labels for Creatine — current prescribing information (label search)
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.